A European provider in life science

Our vision is to improve people's lives by being a leading, value-adding partner in life science

Year-end Report Q4 2023
Graph

Share price

2024-02-25

Press Releases

2024-01-08

Report

2024-02-02

Calendar

  • Strong cash flow and significant actions to improve profitability within Medtech

    Demand is high in the markets and segments where AddLife's companies operate. We can now summarize 2023 as a year with historically strong organic growth of 10%. In the fourth quarter, cash flow improved significantly and net debt decreased by approximately SEK 400 million.

    comments by the ceo
    Fredrik Dalborg Q4 2024 SQ

Our business areas

Medtech

MEDTECH

In the Medtech business area, the subsidiaries offer products and services in the field of medical technology, as well as assistive equipment for use in homecare. Medtech’s offering mainly focuses on public funded health care, homecare and social care in Europe.

Read more
Labtech

LABTECH

The Labtech business area provides products, solutions and services in fields such as diagnostics, biomedical research and laboratory analysis. Customers include hospitals, research laboratories, pharmaceutical companies, and food industry groups, primarily in the Nordics and rest of Europe.

Read more

Join the AddLife group

Do you have a life science company with opportunities to grow? We offer an attractive option with a decentralized business model where we combine the strength of a large enterprise with the dedication and business skills of an entrepreneur. As an AddLife subsidiary you are responsible for your business activities within the AddLife requirements for growth, profitability and sustainable development.

Acquisitions

News from our subsidiaries

Franco Aiolfi
02 February 2024
Euroclone serves science through innovation

Euroclone is an exciting business whose mission to serve science through innovation is represented by searching around the globe all innovation available in the market that represents new frontiers for Biomedical research.

Euroclone
22 January 2024 | triolab oy
Association supporting healthcare

Sailab – MedTech Finland is an association that, together with its member companies, helps the Finnish healthcare system produce the best treatment solutions.

13 January 2024 | Zafe
Smart teknik ger bättre vård

Kristianstadbladet skriver om Zafes tekniska trygghetslösningar för vården.

01 January 2024 | Biomedica Italia
The business unit of the Surgery Division of Euroclone Spa merges into Biomedica Italia Srl.

Today, the branch of Euroclone Spa specializing in the distribution of surgical products merges into Biomedica Italia Srl, another company in the Addlife group.

See all news

Sustainability for AddLife

Sustainability is a central part of AddLife's vision to improve people's life by being a leading, value adding provider in life science. AddLife┬┤s approach to sustainability is identified through three impact areas where we can have the greatest contribution to a long-term lasting business and society.

Adobestock 300716540